{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-005109","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.977032+00:00","generated_at":"2026-05-16T04:57:44.330140+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"bioAffinity Technologies sets 2026 Annual Meeting for April 30; proposal deadline Feb 14","bullets":["Annual Meeting scheduled for April 30, 2026 at company's principal executive offices in San Antonio, TX.","Special Meeting of Stockholders (Dec 19, 2025) adjourned without business due to lack of quorum; proposals will be included in Annual Meeting.","Stockholder proposals or director nominations must be received by Feb 14, 2026, ten days after this announcement.","Details of proposals and proxy statement to be filed with SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-005109","json":"https://secwatch.observer/filing/0001493152-26-005109.json","markdown":"https://secwatch.observer/filing/0001493152-26-005109.md","text":"https://secwatch.observer/filing/0001493152-26-005109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226005109/0001493152-26-005109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226005109/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:57:44.330140+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}